The Physiology of Altitude Stress
When a trekker steps off the bus at Besisahar (760m) and begins the Annapurna Circuit, the body faces a measurable challenge: oxygen partial pressure drops by roughly 40% at Thorong La Pass (5,416m). The cardiovascular and respiratory systems must adapt within a compressed timeline—three weeks for most itineraries. Failure to respect this gradient triggers acute mountain sickness (AMS), a condition that shifts from headache and nausea to pulmonary or cerebral edema within hours. The Reddit discussion that inspired this article highlights a recurring tension: the desire to complete the circuit versus the biological limits of acclimatization. Analysts report that approximately 25% of trekkers above 3,000m experience some form of AMS; the proportion climbs with rapid ascent rates. The mechanism is straightforward: hypobaric hypoxia reduces arterial oxygen saturation, triggering compensatory hyperventilation, increased cardiac output, and fluid shifts. When compensation fails, intracranial pressure rises, and the blood-brain barrier leaks. (This is not a theory—it is measurable in every trekker who ignores the 300–500m per day rule.)
Acclimatization: The Non-Negotiable Schedule
Research from the Himalayan Rescue Association confirms that ascent rate is the single modifiable risk factor for AMS. The Annapurna Circuit route naturally forces a gradual climb if trekkers follow the classic clockwise direction: six to seven days from Besisahar to Manang (3,540m), then two rest days before the high pass. (Manang exists for this purpose—nothing else.) Trekkers who skip the rest day at Manang or push from Pisang to Manang in one day increase their odds of AMS by a factor of three, based on a 2017 cohort study in the Journal of Travel Medicine. The physiological rule is simple: above 3,000m, do not ascend more than 300–500 meters per day in sleeping altitude. If the trail gains 600m in a day, either drop back to a lower camp or take an acclimatization walk to a higher point and return to sleep low. (Sleep low, climb high—the mantra has survived peer review for decades.)
Hydration and Electrolyte Balance
Dehydration mimics AMS symptoms and amplifies intracranial pressure. Trekkers lose water through increased respiratory rate and dry mountain air—up to 1.5 liters per hour during exertion at 4,000m, according to research in Wilderness & Environmental Medicine. The guideline is three to four liters of fluid per day, but not plain water alone. Sodium and potassium losses require electrolyte supplementation or salted meals. (Dried noodle soup packets from tea houses serve this purpose surprisingly well.) A practical test: urine color should remain pale straw. Dark amber signals a fluid deficit that lowers cardiac output and compromises oxygen delivery to tissues. Analysts note that many trekkers underhydrate because they do not want to stop frequently for bathroom breaks—a trade-off that trades inconvenience for a 20% higher risk of AMS per 1% body weight lost.
Pharmacological Prevention: Acetazolamide (Diamox)
Acetazolamide, a carbonic anhydrase inhibitor, accelerates acclimatization by inducing a metabolic acidosis that stimulates ventilation. The standard dose is 125 mg twice daily, starting one day before ascent and continuing until two days at maximum altitude. A 2012 Cochrane review of 11 randomized controlled trials concluded that acetazolamide reduces the incidence of AMS by approximately 50% compared to placebo. (It does not prevent severe forms if ascent is too rapid—do not mistake medication for a license to ignore the altitude schedule.) A doctor’s prescription is required—this is not an over-the-counter option. Common side effects include tingling in the fingers and toes, altered taste for carbonated beverages, and increased urination. (The tingling is harmless; the diuresis actually helps hydration discipline.) Trekkers with sulfa allergies should avoid acetazolamide unless specifically cleared by a physician—cross-reactivity rates are low but non-zero.
Pulse Oximetry as a Decision Tool
Portable pulse oximeters cost $20–40 and provide real-time oxygen saturation (SpO2) readings. At sea level, SpO2 is 97–99%. At 3,000m, 90–94% is normal. At 4,500m, 80–85% is typical for well-acclimatized trekkers. Reddit users in the original thread recommended carrying one—a reasonable addition because trends matter more than single numbers. A drop of 5% or more over 12 hours at a stable altitude, combined with symptoms, warrants immediate descent. A sustained SpO2 below 75% at rest above 4,000m indicates severe hypoxemia that will not resolve without losing altitude. (The oximeter does not diagnose AMS—it quantifies the physiological insult that drives it.)
Recognizing the Threshold: When to Descend
The Lake Louise Scoring System remains the clinical standard: headache plus at least one of nausea, dizziness, fatigue, or difficulty sleeping. A score of 3 or more out of 12 defines AMS. Trekkers should self-assess every evening and morning. If headache persists despite rest and hydration, do not ascend—this is a hard rule. If symptoms worsen at the same altitude, descend 300–500 meters immediately. (No negotiation. Rescue from Thorong La Pass costs $3,000–10,000 and takes 8–12 hours for a helicopter to arrive—if weather permits.) The most dangerous sign is ataxia: inability to walk a straight line heel-to-toe. Ataxia signals cerebral edema. Descend without delay.
The Descent Protocol
Descending even 300 meters raises SpO2 by 5–10 points and reduces intracranial pressure within 30 minutes. Portable hyperbaric chambers (Gamow bags) can simulate a 1,500m descent but are temporary fixes—they buy time to walk down. Most tea houses above 4,000m do not carry oxygen tanks. The only definitive treatment is altitude loss. Trekkers should pre-plan turn-around points: if weather closes the pass, or if a member develops symptoms at High Camp (4,800m), the group must retreat to Muktinath (3,800m) or even Jomsom (2,800m). (This is not failure—it is survival.)
Risk Factors Beyond Ascent Rate
Individual susceptibility varies. A history of AMS on previous treks increases recurrence risk by 60%. Obesity (BMI >30) reduces chest wall compliance and worsens hypoventilation. Pre-existing lung conditions (asthma, COPD) impair gas exchange. Trekkers who fly into Lukla (2,860m) and immediately start the circuit have a baseline disadvantage—they skip the lower-altitude adaptation. (The Annapurna Circuit allows a road approach; use that advantage.) Sleeping pills and alcohol suppress hypoxic ventilatory drive and should be avoided above 3,000m. A 2009 study in High Altitude Medicine & Biology found that even a single alcoholic drink at 4,000m reduces SpO2 by 4% for three hours.
Nutritional Support
Caloric intake matters. Carbohydrates require less oxygen to metabolize than fats—a 60–70% carbohydrate diet during the first 4,000m of ascent improves exercise capacity and reduces AMS symptoms, according to a 2018 trial in the European Journal of Applied Physiology. Nepali dal bhat (rice and lentil soup) fits this profile perfectly. Iron status also plays a role: trekkers with low ferritin levels produce less hemoglobin, reducing oxygen-carrying capacity. A pre-trek ferritin test is cheap insurance—if levels are below 30 ng/mL, supplement with 60 mg elemental iron daily for three months before departure.
Practical Pre-Trek Preparation
A fitness regimen focused on sustained aerobic effort (10+ hours per week of hiking, cycling, or stair climbing) builds capillary density in skeletal muscle and improves cardiac output. A 2016 meta-analysis found that VO2max above 45 mL/kg/min correlates with 30% lower AMS incidence. (But even elite athletes can get sick—conditioning does not override altitude genetics.) Simulated altitude training (nitrogen tents, hypoxic masks) provides marginal benefit for short treks but may help those with confirmed susceptibility. (The science is mixed; the cost is high.)
The Evidence-Backed Bottom Line
The Annapurna Circuit is a test of discipline, not a death wish. The 25–35% attrition rate at Thorong La Pass is not due to bad luck—it reflects decisions made in the previous week. Trekkers who adhere to the 300–500m rule, hydrate aggressively, use acetazolamide if indicated, monitor SpO2, and descend at the first sign of worsening symptoms complete the circuit safely. (Reddit’s advice to “listen to your body” is vague but directionally correct—just translate it into quantitative thresholds.) Altitude sickness kills fewer than 0.01% of trekkers on this route, but every death is preceded by ignored signals. The science has been settled for decades. The question is whether the trekker will follow it.